Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9423866 | Current Opinion in Neurobiology | 2005 | 9 Pages |
Abstract
In the past few years several spontaneous or engineered mouse models with mutations in Ca2+ channel genes have become available, providing a powerful approach to defining Ca2+ channel function in vivo. There have been recent advances in outlining the phenotypes and in the functional analysis of mouse models with mutations in genes encoding the pore-forming subunits of CaV2.1 (P/Q-type), CaV2.2 (N-type) and CaV2.3 (R-type) Ca2+ channels, the channels involved in controlling neurotransmitter release at mammalian synapses. These data indicate that CaV2.1 channels have a dominant and efficient specific role in initiating fast synaptic transmission at central excitatory synapses in vivo, and suggest that the CaV2.1 channelopathies are primarily synaptic diseases. The different disorders probably arise from disruption of neurotransmission in specific brain regions: the cortex in the case of migraine, the thalamus in the case of absence epilepsy and the cerebellum in the case of ataxia.
Related Topics
Life Sciences
Neuroscience
Neuroscience (General)
Authors
Daniela Pietrobon,